RANCHO CORDOVA, Calif., Oct. 2, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned device subsidiary (the "Company"), announced today it has received the $2 million upfront distribution fee pursu

JERSEY CITY, N.J., Oct. 2, 2019 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced that data, which further demonstrates the potential of ibrexafungerp as a treatment for invasive fungal infections, will be presented at IDWeek 2019,

BOCA RATON, Fla., Oct. 2, 2019 /PRNewswire/ -- Celsius Holdings, Inc. (Nasdaq: CELH), maker of the leading global fitness drink, CELSIUS®, today announced the launch of their newest flavor, Grapefruit Melon Green Tea which will initially launch at the 2019 NACS Show, presented by the National Association of Convenience Stores, in Atlant

NEW YORK, Oct. 2, 2019 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO),  is pleased to report that it has entered into a settlement agreement with BioNucleonics Inc. to complete the outright acquisition of the non-opioid cancer bone pain drug Strontium-89 Chloride USP. Q BioMed will assume immediate ownership of the drug, including the aNDA (abbreviated new drug ap

KAPOLEI, Hawaii and TAMPA, Fla., Oct. 2, 2019 /PRNewswire/ -- 'Ohana Health Plan, a WellCare Health Plans, Inc. (NYSE: WCG) company, has donated $10,000 to support YMCA of Honolulu's Healthy Weight and Your Child (HWYC), an evidence-based child weight-management program offere

BAUDETTE, Minn., Oct. 2, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Aspirin and Extended Release Dipyridamole Capsules, 25mg/200mg (the generic equivalent of Aggrenox®).  This launch represents ANI's fifth generic product introduction in 2019.ANI acquired the rights to launch this drug in an acquisi

MONMOUTH JUNCTION, N.J., Oct. 2, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader using its 

NEW YORK, Oct. 2, 2019 /PRNewswire/ -- Xylyx Bio, a pioneer in tissue-specific extracellular matrix biomaterials, today announced the development of

SAN DIEGO, Oct. 2, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis) for the treatment of various cancers including breast, prostate, colorectal and leukemia, today announced the presentation of preclinical data demonst

IRVINE, Calif., Oct. 2, 2019 /PRNewswire/ -- Laser Associated Sciences (LAS), a medical device company based in Irvine, California, announced that its blood flow monitoring system, FlowMet-R, received its 510(k) clearance from the Food and Drug Administration (FDA). This clearance allows LAS to market and sell the FlowMet-R. The non-